SR-9009 (Stenabolic): The Rev-Erbα Endurance Compound

TL;DR

What: SR-9009 (Stenabolic) is a synthetic Rev-Erbα agonist that reprograms circadian metabolic gene expression toward enhanced oxidative capacity.
Mechanism: Activates Rev-Erbα, which suppresses BMAL1 and triggers downstream mitochondrial biogenesis, fatty acid oxidation, and glucose disposal.
Who it’s for: Endurance athletes, Enhanced Men doing cardio work, and anyone exploring exercise-mimetic pharmacology.
Differentiator: Short half-life (~4 hours) demands multi-dose day; oral bioavailability in humans is limited.
Natural Plus angle: Low-dose, cycled, paired with actual cardio — Stenabolic amplifies training, does not replace it.

Deep Biochemistry

Rev-Erbα (NR1D1) is a nuclear receptor that sits at the junction of circadian rhythm and metabolism. It represses transcription of BMAL1, a core clock gene, and controls expression of genes governing lipid metabolism, inflammation, and mitochondrial function. Burris and colleagues at Scripps developed SR-9009 as a pharmacological Rev-Erbα agonist.

When SR-9009 binds Rev-Erbα, the receptor represses BMAL1 and activates a suite of metabolic programs: increased mitochondrial content, higher fatty acid oxidation, reduced plasma triglycerides, and improved glucose tolerance. In rodents, SR-9009 produced endurance gains that mimicked exercise training. These are the findings that made the compound famous in biohacking circles.

Human pharmacokinetics are the main asterisk. SR-9009 has poor oral bioavailability in rodents (sub-10%) and low-millimolar concentrations are needed for receptor activation. Half-life is ~4 hours. Many practitioners therefore split dose 3-4x daily. Injectable routes have been explored but remain off-label.

Tony Huge Laws of Biochemistry Physics Applied

This compound illustrates Law 2 of the Tony Huge Laws of Biochemistry Physics — Chain Optimization. The metabolic chain from glucose/fatty acid uptake to ATP production passes through mitochondrial content, enzyme density, and oxidative capacity. SR-9009 optimizes the whole chain at once via the Rev-Erbα node — it is not pushing one link in isolation but reprogramming the transcription factor that controls many links simultaneously. This is the assembly-line analogy: rather than speeding one station, Rev-Erbα agonism upgrades the blueprint for the entire production line.

Natural Plus Protocol

Dose: 10-30 mg per day, split 3-4 doses (due to short half-life).
Timing: Morning, pre-workout, mid-afternoon, evening.
Cycling: 8 weeks on, 4 weeks off. Do not stack indefinitely.
Stack partners: Actual cardio (the amplification is real but requires a training signal).
Bloodwork: Lipid panel, HbA1c, fasting glucose at baseline and week 8.

Stacking Recommendations

Stack Compound	Pathway	Why It Synergizes
Cardarine (GW-501516)	PPAR-delta	Different nuclear receptor, complementary fatty acid oxidation pathway.
Methylene Blue	ETC electron donor	Direct mitochondrial support pairs with SR-9009 biogenesis signal.
MOTS-c	Mitochondrial peptide	Mitochondrially-encoded peptide; independent exercise-mimetic axis.

Target Audience

Endurance athletes plateauing on training alone. Men doing 45+ minute cardio sessions who want metabolic amplification. Experimental biohackers exploring exercise-mimetic pharmacology.

Timeline / Results Table

Timeframe	What to Expect
Week 1-2	Subjective improvement in endurance sessions — same effort, lower HR.
Week 4	Measurable cardiovascular gains; easier fat loss on a given deficit.
Week 8	Lipid panel typically shows reduced triglycerides.
Week 12	Cycle off. Retain most gains if cardio training is maintained.

Interesting Perspectives

The contrarian take: SR-9009 was hyped in 2013-2015 as “exercise in a pill.” Reality is more nuanced. It amplifies training, but the compound alone produces modest effects. The athletes who got the biggest gains were the ones already training hard.

Emerging angle: Rev-Erbα is increasingly studied in cardiology and metabolic disease. The long-term safety profile in humans is not established — most data is rodent. Treat this as an experimental compound, not a supplement.

Underground pattern recognition: users who stack SR-9009 with actual high-volume cardio see the best body-recomposition results. Those who use it as a replacement for training get nothing.

FAQ

What is SR-9009?

SR-9009 (Stenabolic) is a synthetic Rev-Erba agonist that reprograms metabolic gene expression to enhance endurance and fat oxidation.

How much SR-9009 should I take?

10-30 mg per day split into 3-4 doses due to short half-life.

Is SR-9009 safe?

Human safety data is limited. Treat as experimental. Cycle 8 weeks on, 4 off, with bloodwork.

Can I stack with Cardarine?

Yes — different nuclear receptors, additive endurance effects.

Who should use SR-9009?

Endurance athletes and experienced biohackers exploring exercise-mimetic compounds with actual cardio training.

References

Solt LA, et al. “Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.” Nature, 2012.
Woldt E, et al. “Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy.” Nat Med, 2013.
Burris TP, et al. “Nuclear receptors and their selective pharmacologic modulators.” Pharmacol Rev, 2013.
Duez H, Staels B. “Rev-erb alpha: an integrator of circadian rhythms and metabolism.” J Appl Physiol, 2009.
Banerjee S, et al. “Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour.” Nat Commun, 2014.